Purpose: Resistance to platinum chemotherapy remains a significant problem in ovarian carcinoma.

However, platinum sales rose on buying for investment, said a Tokyo-based trader.

Its primary products are the three main PGMs: platinum, palladium and rhodium.

Results: There was no observed platinum-induced reduction of glomerular function over time.

Strong attachments of ethynylferrocenes to gold and platinum surfaces were also possible.